Journals / Türk Kardiyoloji Derneği Arşivi / 2010 / Cilt: 38 - Sayı: 5

Transcatheter closure of atrial septal defects in a patient with lipomatous hypertrophy of the interatrial septum

İnteratriyal septumda lipomatöz hipertrofinin eşlik ettiği atriyal septal defektlerin transkateter yolla kapatılması: Olgu sunumu

Pages
366–368
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

During a three-year follow-up, no complications were observed pertaining to the procedure or lipomatous tissue.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Lipomatous hypertrophy of the interatrial septum is a rare benign pathology characterized by fatty deposits in the septum and is mostly diagnosed incidentally.
📊
Key Findings & Data:We report on a 65-year-old female patient who underwent successful transcatheter closure of atrial septal defects (ASD) accompanied by lipomatous hypertrophy of the septum.
💡
Conclusion & Impact:During a three-year follow-up, no complications were observed pertaining to the procedure or lipomatous tissue.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Lipomatous hypertrophy of the interatrial septum is a rare benign pathology characterized by fatty deposits in the septum and is mostly diagnosed incidentally. This accumulation mostly causes a globular thickening of the interatrial septum, commonly sparing the fossa ovalis. We report on a 65-year-old female patient who underwent successful transcatheter closure of atrial septal defects (ASD) accompanied by lipomatous hypertrophy of the septum. Both transthoracic and transesophageal echocardiography showed enlargement of the right heart cavities, thickening of the interatrial septum (16 mm) with bright echogenicity, and two separate secundum ASDs measuring 17 mm and 4 mm, respectively. Transcatheter closure of the defects was performed using a 24-mm Amplatzer septal occluder. There was no residual shunt and Holter monitoring was normal after the procedure. During a three-year follow-up, no complications were observed pertaining to the procedure or lipomatous tissue.

Özet

İnteratriyal septumda yağ depolanması şeklinde benign bir patoloji olan lipomatöz hipertrofi nadirdir ve çoğunlukla tesadüfen teşhis edilir. Bu yağ birikimi çoğunlukla fossa ovalis alanı dışında interatriyal septumda küre şeklinde yuvarlak bir kalınlaşmaya neden olur. Bu yazıda, lipomatöz septum hipertrofisinin eşlik ettiği atriyal septal defektlerin (ASD) transkateter yolla başarılı olarak kapatıldığı 65 yaşında bir kadın hasta sunuldu. Transtorasik ve transözofageal ekokardiyografik incelemelerde sağ kalp boşlukları genişlemiş bulundu; interatriyal septum kalınlaşmış (16 mm) ve parlak olarak izlendi; ayrıca, 17 mm ve 4 mm çaplarında iki sekundum ASD saptandı. Defektler transkateter yolla 24 mm Amplatzer septal tıkayıcı cihaz ile kapatıldı. İşlemden sonra şant görülmedi, işlem sonrası Holter incelemesi normal bulundu. Hastanın üç yıllık takibinde, yapılan işlem ve lipomatöz dokuyla ilişkili bir komplikasyonla karşılaşılmadı.

🔖

Cite This Article

POLAT, T. B., KİBAR, A. E., PAÇ, F. A., ARAS, D. (2022). Transcatheter closure of atrial septal defects in a patient with lipomatous hypertrophy of the interatrial septum. Türk Kardiyoloji Derneği Arşivi, Cilt: 38 - Sayı: 5, 366–368. https://ajindex.com/articles/633298

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Stone GW, O’Kell RT, Good TH, Hartzler GO. Lipomatous hypertrophy of the interatrial septum: diagnosis by percutaneous transvenous biopsy. Am Heart J 1990;119:406-8
  2. Fyke FE 3rd, Tajik AJ, Edwards WD, Seward JB. Diagnosis of lipomatous hypertrophy of the atrial septum by two-dimensional echocardiography. J Am Coll Cardiol 1983;1:1352-7
  3. Reyes CV, Jablokow VR. Lipomatous hypertrophy of the cardiac interatrial septum. A report of 38 cases and review of the literature. Am J Clin Pathol 1979;72:785-8
  4. Isner JM, Swan CS 2nd, Mikus JP, Carter BL. Lipomatous hypertrophy of the interatrial septum: in vivo diagnosis. Circulation 1982;66:470-3
  5. Shirani J, Roberts WC. Clinical, electrocardiographic and morphologic features of massive fatty deposits (“lipomatous hypertrophy”) in the atrial septum. J Am Coll Cardiol 1993;22:226-38
  6. Pochis WT, Saeian K, Sagar KB. Usefulness of transesophageal echocardiography in diagnosing lipomatous hypertrophy of the atrial septum with comparison to transthoracic echocardiography. Am J Cardiol 1992;70:396-8
  7. Nobuoka S, Saito K, Miyake F, Abe H, Takakuwa T, Nakamura T. A case of lipomatous hypertrophy of the interatrial septum detected via transthoracic 2 dimensional echocardiography. J Clin Ultrasound 2006;34:313-5
  8. Heyer CM, Kagel T, Lemburg SP, Bauer TT, Nicolas V. Lipomatous hypertrophy of the interatrial septum: a prospective study of incidence, imaging findings, and clinical symptoms. Chest 2003;124:2068-73
  9. Sato Y, Matsuo S, Kusama J, Kunimasa T, Yoda S, Matsumoto N, et al. Lipomatous hypertrophy of the interatrial septum presenting as sick sinus syndrome. Int J Cardiol 2007;119:280-1
  10. Moir WS, McGaw DJ, Harper RW, Gelman J. Images in cardiovascular medicine. Atrial septal defect device closure in a patient with lipomatous hypertrophy of the atrial septum. Circulation 2003;107:e217
  11. Masura J, Gavora P, Formanek A, Hijazi ZM. Transcatheter closure of secundum atrial septal defects using the new self-centering Amplatzer septal occluder: initial human experience. Cathet Cardiovasc Diagn 1997;42:388-93.